Strumento inattivo

Altre lingue NVN Liquidation, Inc.

Azioni

NVN Liquidation, Inc. Announces Board Resignations	01/05
First Amended Combined Liquidation Plan and Disclosure Statement Filed by NVN Liquidation, Inc.	17/01
Modified Disclosure Statement Approved on Interim Basis for NVN Liquidation, Inc.	19/12
First Motion for Exclusivity Period Extension Approved For NVN Liquidation, Inc.	01/12
Combined Liquidation Plan and Disclosure Statement Filed by NVN Liquidation, Inc.	22/11
First Motion for Exclusivity Period Extension Filed by NVN Liquidation, Inc.	13/11
Novan, Inc. has Changed its Name to NVN Liquidation, Inc	20/10/23
Novan, Inc. Announces the Resignation of John M. Gay as Chief Financial Officer	27/09/23
Novan, Inc. Announces the Resignation of John M. Gay as Secretary	27/09/23
Ligand Pharmaceuticals Incorporated completed the acquisition of Substantially All of the Assets of Novan, Inc. for $12.2 million.	27/09/23
Motion for Asset Sale Approved for Novan, Inc.	12/09/23
Motion for Asset Sale Approved for Novan, Inc.	12/09/23
Notice of selection of Successful Bidder Filed by Novan, Inc.	01/09/23
Notice of selection of Successful Bidder Filed by Novan, Inc.	31/08/23
Final DIP Financing Approved for Novan, Inc.	21/08/23
Bidding Procedure Approved for Novan, Inc.	15/08/23
Novan, Inc.(OTCPK:NOVN.Q) dropped from NASDAQ Composite Index	25/07/23
Interim DIP Financing Approved for Novan, Inc.	21/07/23
Novan, Inc.(NasdaqCM:NOVN) dropped from S&P TMI Index	20/07/23
Motion for Joint Administration Approved for Novan, Inc.	19/07/23

Non ci sono risultati per questa ricerca